Pages

Search This Blog

Wednesday, August 24, 2022

Pfizer seeks authorization for new Covid booster, without fresh clinical data

Pfizer seeks authorization for new Covid booster, without fresh clinical data: Pfizer seeks authorization for updated Covid vaccine, without fresh clinical trial data

No comments: